Analyst Undervalued Stocks on the NAS December 2024

December 09, 2024

Analyst Undervalued

Companies on this list are considered undervalued based on the analyst consensus. This means that the average analyst target price is greater than the close price.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

About the Data

This table includes the close price and analyst target price mean from most recent available data. The fiscal year indicates the year for the analyst target price, as the target may not always be for the current year. The number of estimates indicates the number of analyst targets used to calculate the target price mean.

How do you use this table?

Analysts believe that the companies on this list will see the close price move up to their target price mean by the target year indicated. Companies with a large analyst following or large difference between close price and target price are particularly interesting to investigate further. This becomes a starting point for further analysis to understand why these companies are undervalued. Stocks in this category are generally held for capital appreciation or dividends.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose PriceTarget Price MeanTarget YearNumber of EstimatesCurrency
MELI MercadoLibre Inc 1947.18 2400.00 2025 1 USD
MSTR MicroStrategy Inc 395.01 555.00 2025 2 USD
KLAC KLA Corp 648.34 757.50 2025 2 USD
REGN Regeneron Pharmaceuticals Inc 778.00 1121.40 2025 5 USD
SNPS Synopsys Inc 517.28 640.00 2025 1 USD
ROP Roper Technologies Inc 551.20 648.00 2025 2 USD
MPWR Monolithic Power Systems Inc 589.68 750.00 2025 2 USD
BIIB Biogen Inc 157.78 259.40 2025 5 USD
FSLR First Solar Inc 194.19 322.20 2025 5 USD
UTHR United Therapeutics Corp 369.67 480.00 2025 3 USD
All data provided as at market close December 08, 2024.

Company Details

MercadoLibre Inc

MELI:NAS

Close Price

1947.18

Target Price Mean

2400.00

Target Year

2025

Target Price # Estimates

1

MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions as of the end of 2023.

Access the stockcalc valuation


MicroStrategy Inc

MSTR:NAS

Close Price

395.01

Target Price Mean

555.00

Target Year

2025

Target Price # Estimates

2

MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web; MicroStrategy Server, which provides analytical processing and job management.

Access the stockcalc valuation


KLA Corp

KLAC:NAS

Close Price

648.34

Target Price Mean

757.50

Target Year

2025

Target Price # Estimates

2

KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market.

Access the stockcalc valuation


Regeneron Pharmaceuticals Inc

REGN:NAS

Close Price

778.00

Target Price Mean

1121.40

Target Year

2025

Target Price # Estimates

5

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Synopsys Inc

SNPS:NAS

Close Price

517.28

Target Price Mean

640.00

Target Year

2025

Target Price # Estimates

1

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design.

Access the stockcalc valuation


Roper Technologies Inc

ROP:NAS

Close Price

551.20

Target Price Mean

648.00

Target Year

2025

Target Price # Estimates

2

Roper Technologies is a diversified technology company that operates three segments: application software, network software, and technology enabled products. Roper acquires asset light, cash generative businesses and deploys excess cash to acquire further portfolio companies.

Access the stockcalc valuation


Monolithic Power Systems Inc

MPWR:NAS

Close Price

589.68

Target Price Mean

750.00

Target Year

2025

Target Price # Estimates

2

Monolithic Power Systems is an analog and mixed-signal chipmaker, specializing in power management solutions. The firm's mission is to reduce total energy consumption in end systems, and it serves the computing, automotive, industrial, communications, and consumer end markets. MPS uses a fabless manufacturing model, partnering with third-party chip foundries to host its proprietary BCD process technology.

Access the stockcalc valuation


Biogen Inc

BIIB:NAS

Close Price

157.78

Target Price Mean

259.40

Target Year

2025

Target Price # Estimates

5

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity.

Access the stockcalc valuation


First Solar Inc

FSLR:NAS

Close Price

194.19

Target Price Mean

322.20

Target Year

2025

Target Price # Estimates

5

First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.

Access the stockcalc valuation


United Therapeutics Corp

UTHR:NAS

Close Price

369.67

Target Price Mean

480.00

Target Year

2025

Target Price # Estimates

3

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
MercadoLibre and MicroStrategy are among the most undervalued NAS stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nas-december-2024
MercadoLibre $MELI and MicroStrategy $MSTR on the #NAS among the most undervalued this month. See the full list of undervalued companies: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nas-december-2024
MercadoLibre and MicroStrategy are among the most undervalued NAS stocks this month. See the most undervalued companies on the blog: https://www.stockcalc.com/Blog/analyst-undervalued-stocks-nas-december-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.